Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma
Figure 8.Immunotherapy sensitivity and tumor mutation burden analysis. (A–H) Expression levels of representative immune checkpoints between high and low risk group. (I) Tumor mutation analysis of high and low risk group.